Today was a shortened trading day, so there may need to be more (resistance) confirmation in the coming sessions.
With that, we can see the biotech index SPBIO, has stalled at resistance.
The chart shows there were five-months of support, broken to the downside, now becoming resistance
Biotech SPBIO, Daily
As stated in the last update, the market itself is not giving indications the current short position, LABD-24-21, requires and exit (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Not presented at that time, the apparent Fibonacci count from the left-most channel contact to the latest daily high contact (Friday).
From a trading perspective, from a position of being short this market (LABD-24-21), there’s no specific indication to exit the position (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Hey, Rocky! … Watch Me Pull Hyperbole Out of my Hat
The financial press says, on Friday, the shorts got slaughtered.
Is that true, or just more hyperbole?
To find out, we’ll take a look at the active short in biotech XBI, and see if there was a ‘slaughter’, or something more constructive.
Biotech XBI, Daily
The last post inferred, ‘there’s no end in sight’ (not advice, not a recommendation).
Is that still true?
A present, we have a channel (with center-line) whose sections are a Fibonacci multiple.
If the channel is still in effect and the next session does not decisively break to the upside, then we can see price action is testing and validation that right side.
The good part or scary part depending on one’s perspective, XBI is validating the ‘supply’ side of the channel (where selling occurs).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
As far as known, feel free to comment to the contrary, this site’s the only one that incorporates outage potential (and reality) into its trading plan.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
While confusion in the rest of the market rages on, Trump-bump, no-bump, consumer optimism never higher, back at the ranch, biotech XBI, is posting some ominous signs (not advice, not a recommendation).
With a backdrop of ‘the jig is up’ for some sectors, it’s possible, biotech is part of that (potential) long term reversal as well.
Biotech XBI, Daily
The work has already been done, showing the potential of a significant reversal, link here.
As stated in previous posts, the corporate account is positioned short; tracked via LABD-24-21, in the side bar above (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Is a long-term, downside reversal in this sector, about to bubble to the surface?
With yesterday’s update, it’s easy to get lost in the hourly and daily maneuvers; see a likely (short-term) potential, while it just distracts from the bigger picture.
That ‘big picture’, is below.
Once again, we have a (potential) repeating set-up: Wyckoff ‘Spring-to-Up-Thrust.
Biotech XBI, Weekly Close
With this week’s volatile action but lower overall close (from last week), the ‘up-thrust test may be complete (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.